Eulav Asset Management Omnicell, Inc Transaction History

Eulav Asset Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 27, 2020	BUY	$55.41 - $90.19 $808,986 - $1.32 Million	14,600 Added 35.1%	56,200 $3.69 Million
Q2 2019 Aug 05, 2019	BUY	$71.38 - $92.21 $899,388 - $1.16 Million	12,600 Added 43.45%	41,600 $3.58 Million
Q1 2019 May 13, 2019	BUY	$58.88 - $86.19 $235,520 - $344,760	4,000 Added 16.0%	29,000 $2.33 Million
Q4 2018 Feb 14, 2019	BUY	$56.97 - $77.23 $564,003 - $764,577	9,900 Added 65.56%	25,000 $1.53 Million
Q3 2018 Oct 26, 2018	BUY	$52.65 - $71.9 $795,015 - $1.09 Million	15,100 New	15,100 $1.09 Million

285

44.7M

224K

35.7K

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $1.83B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

Stay updated on Eulav Asset Management with notifications on news.